Viekira rocking it!! NOT

...blowing him? I will be right home!

 

The biggest writer of Hep C in the southeast is a speaker and has yet to write a single script. This says it all.

 

So many of our speakers haven't written VPak yet it's not even funny. Half of them don't believe in the drug.

 

Gotta love our speakers! ACTIONS speak louder than words.

 

I thought he was a personal friend of Catherine C-R?????

 

Are you sure it is half?? Too high in my opinion

 

Just because you pay them to speak, doesn't mean he's a personal friend.

 

Viekira: Prescr. figures for wk ending 1/23 (Symphony/BBG) : TRx@ 204. NRx@ 195.
Harvoni + sovaldi: TRx@ 9,935. NRx@ 5,251

We are dead...2.01% ms.

 

Analysts' say we are going make $3Billion this year. So f off negative posters!

 

Woohoo another big increase this week. You are SO wrong! This dog really can hunt!

 

Goody for you. Headcount still isn't justified. Too many of us we're oversaturated oh and yea underperforming despite what the analysts' "say." I wouldn't bank on long term employment in HCV.

 

Yeah it's Lootzie's weiner dog, a dachshund!

 

(Bloomberg) -- AbbVie Inc. shares dropped after the company said sales of its new hepatitis C drug, projected to be a blockbuster, would be slower than investors and analysts previously projected.

 

After we pay for our shire boo boo we'll have a cool 1.5 B when we expected bazillions. Buh bye.

 

after that news, next order of business...thinning of the layers...layoffs.

 

Analysts predict 2015 US sales for VPak to be about $1.5B. Gileads Harvoni sales predicted to be $14B. After expences you're in the negative. Thats a hard pill to swollow. The BOD will not let share holder value decline to a point of no return. My prediction is that they will back off on aggressive promotion and focus on future options.